By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MabVax Therapeutics, Inc. 

11588 Sorrento Valley Road
Suite 20
San Diego  California  92121  U.S.A
Phone: 858-259-9405 Fax:



Company News
MabVax Therapeutics Humab-5B1 Based Diagnostic Imaging And Radioimmunotherapy Programs Featured At The 2016 World Molecular Imaging Congress 9/26/2016 10:13:40 AM
MabVax Therapeutics Delivering 1-2 Punch with "Diagnose And Destroy" Cancer Pipeline 9/20/2016 9:26:09 AM
MabVax Therapeutics Reports On Interim Progress On Its Programs Including The Phase I Clinical Trial For Therapeutic Antibody Treatment Of Pancreatic Cancer 9/19/2016 7:35:46 AM
Oncology Biotech Standout MabVax Therapeutics Interviewed On Small Cap Nation 9/16/2016 9:25:07 AM
MabVax Therapeutics Provides Webcast Presentation At Rodman & Renshaw Conference 9/15/2016 11:55:32 AM
MabVax Therapeutics Issues Letter To Shareholders Post Uplisting Onto The Nasdaq Capital Market 9/8/2016 9:45:28 AM
MabVax Therapeutics To Present At The 18th Annual Rodman & Renshaw Global Investment Conference 8/31/2016 11:12:23 AM
MabVax Therapeutics Announces The Closing Of Its Public Offering 8/22/2016 7:22:27 AM
MabVax Therapeutics Announces Uplisting To The Nasdaq Capital Market And $8.625 Million Public Offering 8/17/2016 6:45:21 AM
MabVax Therapeutics Initiates Patient Enrollment In A Phase I Trial For A New Diagnostic Imaging Product For Pancreatic Cancer 7/18/2016 6:32:45 AM